engineered t-cells to prevent gvhd in leukemia
Published 2 years ago • 215 plays • Length 4:21Download video MP4
Download video MP3
Similar videos
-
2:05
using engineered t-cells to suppress acute gvhd and leukemia relapse after allosct
-
3:30
targeting t-cell, b-cell & apc activation to treat chronic gvhd
-
5:29
targeting cd1c-expressing leukemia with engineered t-cells
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:12
managing gvhd in patients undergoing sct
-
12:50
3mensio ct pre-case planning: mitral valve-in-ring (mvir) tmvr
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
4:01
certified stem cell iv treatment - 50 million mesenchymal placenta stem cells iv
-
1:23
t-cell metabolism: a novel therapeutic avenue for gvhd
-
2:16
gvhd prophylaxis post-allosct: ptcy versus atg
-
3:52
the gvl effect of vsts
-
3:17
tcxpress™ vs car-t therapy & targeting leukemia with tcr t-cells
-
2:53
the utility of cd34-selected peripheral blood stem cell graft as gvhd prevention in hla allografts
-
1:58
logistics for a technique to avoid gvhd
-
2:20
itacitinib for the prophylaxis of gvhd and crs in t-cell replete haploidentical pbsct
-
2:26
belimumab for the prophylaxis of chronic gvhd
-
3:39
hsct with t-cell add-back of rivogenlecleucel in acute leukemia
-
6:35
post-transplant bendamustine for gvhd prophylaxis in refractory acute leukemia
-
10:24
b-t cell interactions in gvhd
-
1:50
translational and clinical advances in acute gvhd
-
4:52
atg and/or post-cy for gvhd prophylaxis
-
1:10
cell expansion and vector design in novel t-cell therapies